Drugs / PG4 vaccine
last change Jul 2025 re-read 2 minutes ago

PG4 vaccine

Vaccine

Developed for
pneumococcal infection
Investigated by
Pfizer

Trials 1 · a red edge is where a trial was stopped

20262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT07086677 Jul 2025 → Oct 2027 expected pneumococcal infection Pfizer Active not recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PG4 vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT07086677
Modality Vaccine “experimental PG4 vaccineNCT07086677